IL33 and chronic obstructive pulmonary disease: Since sST2 acts as a decoy receptor for IL-33, and IL-33 can induce sST2 production, one could speculate that increased circulating sST2 in COPD reflects increased local IL-33 expression and aggravated inflammatory response in the lungs.